Wednesday, 18 Sep 2019

Belectric OPV wins the AIT Innovation Award Architecture + Building at BAU 2017

Organic photovoltaics are set to become an important and highly promising technology in the world-wide adoption and integration of photovoltaics (PV) into buildings

16 Jan 2017 | Editor

Belectric OPV has announced that its OPV product line OPVIUS, co-developed with Merck received the Innovation Award Architecture + Building at the BAU 2017. The exhibited active solar films produced by Belectric OPV under the brand name Opvius use Merck's latest generation of lisicon materials and were optimised for building integrated photovoltaics (BIPV).

According to Belectric in order to meet the 2050 CO2 emission targets, nearly zero-energy buildings will become generally mandatory in the EU from 2021 on. To reach these new standards the use of renewables will be essential and BIPV, meaning active electricity generation in the building envelope, will be a key enabler.

Belectric continued to add, organic photovoltaics constitute an important and highly promising technology in the world-wide adoption and integration of photovoltaics (PV) into buildings. OPV is a fundamentally different approach compared to classical PV, and uses cost effective and eco-friendly roll-to-roll manufacturing.

The printed OPV modules are thin and flexible laminates, which are easily added to a variety of construction materials and are compatible with standard glass lamination process. In addition, the larger inherent freedom of design and versatile adaptability also allow OPV to better serve functional and aesthetic demands from architects compared to classic PV technologies.

Examples are the unique choice of colours, shapes and degrees of transparency, which strongly improve the prospects to comply with preferred façade designs.

Furthermore, the flexible and light-weight nature of OPV allows the straightforward compatibility with upcoming membrane architecture and other light-weight solutions.

David Müller, Head of Marketing Photovoltaics at Merck, said,"Building integrated PV will play an essential role in future energy-efficient buildings, but existing solutions often do not satisfy the needs of architects. We are particularly encouraged by the decision of the jury of renowned architects to acknowledge OPV for satisfying both design and functionality."
Mr. Hermann Issa, Senior Director of Business Development and Sales at Belectric OPV, said, "Organic PV is no longer an R&D topic. Together with further specialized partners, we have realized several reference projects with completely different requirements and setups in the last several years." Hermann added, "Working with our partner Carl Stahl, we have integrated OPV active laminates into the Solar Trees for the German Pavilion at the EXPO 2015 in Milan. Additionally, with BGT (Bischoff Glastechnik AG) we have installed laminated OPV module in the glass façades of different buildings while together with Taiyo Europe we have integrated OPV in ETFE membranes. This shows the nearly endless possibilities OPV can offer."

www.merck.de    www.solarte.de   

About Belectric OPV GmbH

Belectric OPV, based in Nuremberg and Kitzingen, is the market leader in organic photovoltaics. Belectric OPV produces organic solar cells, with a focus on customised solutions.

In addition, Belectric OPV is committed to research and development continuously offering customers creative and innovative solutions.

Belectric OPV uses a unique manufacturing process based on a combination of printing, lamination and laser structuring methods. This advanced technology enables a high level of scalability and allows extreme individual and customised product designs.

Belectric OPV supports its customers with complete system solutions when it comes to integration of OPV into existing or new products. The company markets its products and engineering services under two product lines: "SOLARTE" for architects and designers, and "PowerPlastic" for large-scale industrial applications.

Source: Belectric OPV GmbH

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the Merck KGaA, Darmstadt, Germany, name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Source: Merck

cintelliq logo